Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher L King

Showing results (101-110 of 178) with videos related to

Pageof 18
Sort By:
Malaria Journal|April 17, 2025
[Effect of low-dose primaquine treatment on Plasmodium vivax recurrence and transmission-blocking activity in southwest Ethiopia: a longitudinal cohort studyHallelujah Getachew, Kassahun Habtamu, Ashenafi Abossie, et al.
Infection and Immunity|February 18, 2016
Protective Effect of Chronic Schistosomiasis in Baboons Coinfected with Schistosoma mansoni and Plasmodium knowlesiRuth K Nyakundi, Onkoba Nyamongo, Jeneby Maamun, et al.
The American Journal of Tropical Medicine and Hygiene|July 8, 2011
Serologic evidence of arboviral infections among humans in KenyaLaura J Sutherland, Ayla A Cash, Yan-Jang Scott Huang, et al.
Infection and Immunity|January 14, 2009
Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illnessDanielle I Stanisic, Jack S Richards, Fiona J McCallum, et al.
The Journal of Infectious Diseases|November 6, 2004
Increased ratio of tumor necrosis factor-alpha to interleukin-10 production is associated with Schistosoma haematobium-induced urinary-tract morbidityAlex N Wamachi, Jyoti S Mayadev, Peter L Mungai, et al.
Nature Communications|March 22, 2021
Naturally acquired blocking human monoclonal antibodies to Plasmodium vivax reticulocyte binding protein 2bLi-Jin Chan, Anugraha Gandhirajan, Lenore L Carias, et al.
Plos Neglected Tropical Diseases|January 27, 2025
Alternative approaches for monitoring and evaluation of lymphatic filariasis following mass drug treatment with ivermectin, diethylcarbamazine and albendazole in East New Britain Province, Papua New GuineaKrufinta Bun, Benedict Mode, Melinda Susapu, et al.
Plos Neglected Tropical Diseases|March 17, 2020
The safety of combined triple drug therapy with ivermectin, diethylcarbamazine and albendazole in the neglected tropical diseases co-endemic setting of Fiji: A cluster randomised trialMyra Hardy, Josaia Samuela, Mike Kama, et al.
European Journal of Immunology|August 24, 2017
Patterns of protective associations differ for antibodies to P. falciparum-infected erythrocytes and merozoites in immunity against malaria in childrenJo-Anne Chan, Danielle I Stanisic, Michael F Duffy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 22, 2015
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian FilariasisEdward K Thomsen, Nelly Sanuku, Manasseh Baea, et al.
Pageof 18

Showing results (101-110 of 178) with videos related to

Sort By:
Pageof 18
Malaria Journal|April 17, 2025
[Effect of low-dose primaquine treatment on Plasmodium vivax recurrence and transmission-blocking activity in southwest Ethiopia: a longitudinal cohort studyHallelujah Getachew, Kassahun Habtamu, Ashenafi Abossie, et al.
Infection and Immunity|February 18, 2016
Protective Effect of Chronic Schistosomiasis in Baboons Coinfected with Schistosoma mansoni and Plasmodium knowlesiRuth K Nyakundi, Onkoba Nyamongo, Jeneby Maamun, et al.
The American Journal of Tropical Medicine and Hygiene|July 8, 2011
Serologic evidence of arboviral infections among humans in KenyaLaura J Sutherland, Ayla A Cash, Yan-Jang Scott Huang, et al.
Infection and Immunity|January 14, 2009
Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illnessDanielle I Stanisic, Jack S Richards, Fiona J McCallum, et al.
The Journal of Infectious Diseases|November 6, 2004
Increased ratio of tumor necrosis factor-alpha to interleukin-10 production is associated with Schistosoma haematobium-induced urinary-tract morbidityAlex N Wamachi, Jyoti S Mayadev, Peter L Mungai, et al.
Nature Communications|March 22, 2021
Naturally acquired blocking human monoclonal antibodies to Plasmodium vivax reticulocyte binding protein 2bLi-Jin Chan, Anugraha Gandhirajan, Lenore L Carias, et al.
Plos Neglected Tropical Diseases|January 27, 2025
Alternative approaches for monitoring and evaluation of lymphatic filariasis following mass drug treatment with ivermectin, diethylcarbamazine and albendazole in East New Britain Province, Papua New GuineaKrufinta Bun, Benedict Mode, Melinda Susapu, et al.
Plos Neglected Tropical Diseases|March 17, 2020
The safety of combined triple drug therapy with ivermectin, diethylcarbamazine and albendazole in the neglected tropical diseases co-endemic setting of Fiji: A cluster randomised trialMyra Hardy, Josaia Samuela, Mike Kama, et al.
European Journal of Immunology|August 24, 2017
Patterns of protective associations differ for antibodies to P. falciparum-infected erythrocytes and merozoites in immunity against malaria in childrenJo-Anne Chan, Danielle I Stanisic, Michael F Duffy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 22, 2015
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian FilariasisEdward K Thomsen, Nelly Sanuku, Manasseh Baea, et al.
Pageof 18